Virtu Financial’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15K | Buy |
+34,495
| New | +$15K | ﹤0.01% | 1286 |
|
|
2024
Q1 | – | Sell |
-1,565
| Closed | -$17K | – | 2102 |
|
|
2023
Q4 | $17K | Buy |
+1,565
| New | +$17K | ﹤0.01% | 1344 |
|
|
2023
Q1 | – | Sell |
-1,159
| Closed | -$13K | – | 2102 |
|
|
2022
Q4 | $13K | Buy |
1,159
+661
| +133% | +$7.41K | ﹤0.01% | 1348 |
|
|
2022
Q3 | $12K | Buy |
+498
| New | +$12K | ﹤0.01% | 1497 |
|
|
2022
Q2 | – | Sell |
-1,226
| Closed | -$87K | – | 2078 |
|
|
2022
Q1 | $87K | Sell |
1,226
-100
| -8% | -$7.1K | 0.01% | 1006 |
|
|
2021
Q4 | $90K | Buy |
1,326
+557
| +72% | +$37.8K | 0.01% | 1173 |
|
|
2021
Q3 | $88K | Sell |
769
-231
| -23% | -$26.4K | 0.01% | 1179 |
|
|
2021
Q2 | $151K | Sell |
1,000
-867
| -46% | -$131K | 0.01% | 1093 |
|
|
2021
Q1 | $318K | Buy |
1,867
+1,449
| +347% | +$247K | 0.02% | 783 |
|
|
2020
Q4 | $40K | Buy |
+418
| New | +$40K | ﹤0.01% | 1265 |
|
|
2019
Q2 | – | Sell |
-376
| Closed | -$64K | – | 1852 |
|
|
2019
Q1 | $64K | Buy |
376
+327
| +667% | +$55.7K | ﹤0.01% | 1174 |
|
|
2018
Q4 | $7K | Sell |
49
-86
| -64% | -$12.3K | ﹤0.01% | 1457 |
|
|
2018
Q3 | $88K | Buy |
+135
| New | +$88K | 0.01% | 1208 |
|
|
2018
Q2 | – | Sell |
-1
| Closed | -$4K | – | 2499 |
|
|
2018
Q1 | $4K | Sell |
1
-33
| -97% | -$132K | ﹤0.01% | 1870 |
|
|
2017
Q4 | $152K | Buy |
34
+24
| +240% | +$107K | 0.01% | 1782 |
|
|
2017
Q3 | $79K | Buy |
+10
| New | +$79K | ﹤0.01% | 2129 |
|